Holen Sie sich die Stockscreener-App
0.5895
0.52%
-0.0075
Handel nachbörslich:
.59
0.0005
+0.08%
Schlusskurs vom Vortag:
$0.597
Offen:
$0.597
24-Stunden-Volumen:
121.36K
Relative Volume:
0.10
Marktkapitalisierung:
$2.64M
Einnahmen:
$15.74M
Nettoeinkommen (Verlust:
$-12.86M
KGV:
-0.00255
EPS:
-231.1302
Netto-Cashflow:
$-8.71M
1W Leistung:
-5.54%
1M Leistung:
-64.22%
6M Leistung:
-96.19%
1J Leistung:
-95.49%
1-Tages-Spanne:
$0.5805
$0.5987
1-Wochen-Bereich:
$0.57
$0.6396
52-Wochen-Spanne:
$0.5103
$168.00
22nd Century Group, Inc. Stock (XXII) Company Profile
Firmenname
22nd Century Group, Inc.
Sektor
Branche
Telefon
716-270-1523
Adresse
8560 Main Street, Williamsville, NY
Compare XXII vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
0.5919 | 2.66M | 15.74M | -12.86M | -8.71M | -231.13 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-21 | Eingeleitet | Alliance Global Partners | Buy |
| 2022-06-15 | Eingeleitet | Craig Hallum | Buy |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-23 | Eingeleitet | Cowen | Outperform |
| 2017-10-16 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-08-11 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
22nd Century Group, Inc. Aktie (XXII) Neueste Nachrichten
XXII News | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
22nd Century launches VLN cigarettes in California stores - Investing.com UK
22nd Century launches VLN cigarettes in California stores By Investing.com - Investing.com South Africa
22nd Century Group (Nasdaq: XXII) Launches Pinnacle VLN® Trial in California, Opening Another Major New State for Reduced-Nicotine Cigarettes - The Manila Times
22nd Century Group, Inc. Announces Expansion of Pinnacle VLN into State of California Through Initial Approximately 60-Store Retail Trial - marketscreener.com
XXII Technical Analysis | Trend, Signals & Chart Patterns | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
XXII Stock Price, Quote & Chart | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
22nd Century Group (Nasdaq: XXII) Expands High-Margin Pinnacle Platform With Launch of Pinnacle Pure at Major U.S. Retailers - Sahm
New Pinnacle Pure cigarettes headed to 2,000+ U.S. stores in 2026 - Stock Titan
22nd Century Group, IncCommon Stock (NQ: XXII - FinancialContent
22nd Century Group Expands Distribution of VLN® Cigarettes to 150 New Locations in Metro New York and Northern New Jersey - Quiver Quantitative
22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle Brand - The Manila Times
22Nd Century Group Expands Pinnacle Vln Retail Presence in Metro New York and Northern New Jersey - marketscreener.com
FDA-authorized low-nicotine cigarettes target 800k NYC-area smokers - Stock Titan
22nd Century Group, Inc. (NASDAQ:XXII) Q1 2026 Earnings Call Transcript - Insider Monkey
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications - 2Firsts
22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review - The Manila Times
22nd Century Group Seeks FDA Renewal for VLN® as Modified Risk Tobacco Product - geneonline.com
XXII | 22nd Century Group Inc. FinancialsIncome Statement - Quiver Quantitative
22nd Century Group Seeks Renewal of Modified Risk Tobacco Product Status for VLN® King and VLN® Menthol King Cigarettes - Quiver Quantitative
Cigarettes with 95% less nicotine face new FDA review - Stock Titan
Fda to review two modified risk tobacco product renewal applications from 22nd Century Group - marketscreener.com
FDA To Review Two Modified Risk Tobacco Product Renewal Applications From 22nd Century Group - TradingView
22nd Century slightly lowers first-quarter loss; no net revenue from very-low-nicotine cigarettes - Winston-Salem Journal
FDA Files MRTP Renewal for Two 22nd Century Products - Tobacco Reporter
XXII Q1 2026 Earnings Call Transcript - The Globe and Mail
MSN Money - MSN
Number of shareholders of 22nd Century Group, Inc – NASDAQ:XXII - TradingView
22Nd Century Group IncQ1 Net Revenues Incr - Moomoo
Q1 2026 22nd Century Group Inc Earnings Call Transcript - GuruFocus
22nd Century Group, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
22nd Century: Q1 Earnings Snapshot - theheraldreview.com
22nd Century Group 1Q Loss $3.3M >XXII - Moomoo
Earnings call transcript: 22nd Century Group reports Q1 2026 financials By Investing.com - Investing.com South Africa
XXII: Sequential revenue up 16% in Q1 2026 as VLN retail expansion accelerates - TradingView
Earnings call transcript: 22nd Century Group reports Q1 2026 financials - Investing.com India
22nd Century Group Releases Q1 2026 Financial Results - AlphaStreet
22nd Century Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
22nd Century Group (NASDAQ: XXII) posts Q1 2026 loss and flags going concern risk - Stock Titan
Revenue falls at 22nd Century (NASDAQ: XXII) as VLN push grows - Stock Titan
22nd Century puts low-nicotine cigarettes in 2,000 stores - Stock Titan
22nd Century Group Ended 1Q With Cash and Cash Equivalents of $9.5M >XXII - Moomoo
22nd Century Group Reports First Quarter 2026 Financial Results - Yahoo Finance
XXII Price Today: 22nd Century Group Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
22nd Century Announced May 7 Financial Call - Tobacco Reporter
Dow Falls Over 150 Points; Tyson Foods Posts Upbeat Earnings - Benzinga
22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026 - The Manila Times
22nd Century to post Q1 results at 6 a.m., webcast at 8 - Stock Titan
Finanzdaten der 22nd Century Group, Inc.-Aktie (XXII)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.49%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):